Sodium bicarbonate

Alternative Names: sodium bicarbonate, sodium bicarbonate in plastic container, sodio bicarbonato, natriumhydrogencarbonat, bicarbonato de sodio, golytely, nulytely, colyte with flavor packs, colyte-flavored, glycoprep, go-evac, konvomep, baros, prismasol bgk 4/0 in plastic container, prismasol b22gk 2/0 in plastic container, phoxillum b22k 4/0 in plastic container, prismasol bk 0/3.5 in plastic container, prismasol bgk 4/2.5 in plastic container, prismasol bgk 4/3.5 in plastic container, colyte, e-z-em prep lyte, prismasol b22gk 4/2.5 in plastic container, prismasol bgk 2/0 in plastic container, trilyte, nulytely-flavored, normocarb hf 35, lax-lyte with flavor packs, prismasol bk 0/0/1.2 in plastic container, prismasol bk 0/0 in plastic container, prismasol b22gk 2/2.5 in plastic container, clenz-lyte, peg-lyte, colovage, prismasol b22gk 4/0 in plastic container, co-lav, bss plus, prismasol bgk 2/3.5 in plastic container, phoxillum bk 4/2.5 in plastic container, elliotts b solution, prismasol bk 4/2.5 in plastic container, ocl, prismasol bgk 4/0/1.2 in plastic container, navstel, prismasol bgk 0/2.5 in plastic container, normocarb hf 25, suclear, gavilyte - n, elliotts b, prismasol bgk2/0, prismasol b22gk4/0, prismasol bgk2/3.5, prismasol bgk4/2.5, prismasol bgk0/2.5, phoxillum bk4/2.5, prismasol bk0/0/1.2, prismasol bgk4/0/1.2, phoxillum b22k4/0, nulytely with flavor packs
Latest Update: 2025-04-21
Latest Update Note: News Article

Product Description

Sodium bicarbonate is a chemical compound made of sodium (Na+) and bicarbonate (HCO3-), for which the indications are many. FDA approved indications include: Cardiac conduction delays and QRS prolongation (ex. tricyclic antidepressant poisoning) (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK559139/)

Mechanisms of Action: Calcium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: None *

Approval Status: Approved

Approved Indications: None

Known Adverse Events: None

Company: GSK
Company Location: BRENTFORD MIDDLESEX X0 TW8 9GS
Company CEO: Emma Walmsley
Additional Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sodium bicarbonate

Countries in Clinic: China

Active Clinical Trial Count: 2

Highest Development Phases

Phase 3: Dystocia

Phase 1: Duodenal Ulcer|Esophagitis|Zollinger-Ellison Syndrome

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
SoBicOL-II	P3	Not yet recruiting	Dystocia	2025-06-30
CTR20243909	P1	Recruiting	Zollinger-Ellison Syndrome\|Duodenal Ulcer\|Esophagitis	None

Date	Type	Title
04/21/2025	News Article	New WARHEADS Atomic Fizz comes with real explosions
04/14/2025	News Article	UroGen Announces Data Presentations at the American Urological Association 2025 Annual Meeting Highlighting Emerging Evidence Supporting Our Portfolio for Urothelial Cancers
04/02/2025	News Article	Church & Dwight to Webcast Discussion of First Quarter 2025 Earnings Results on May 1
03/10/2025	News Article	UroGen Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Announces Updated 18-Month Duration of Response (DOR) of 80.6% from the Phase 3 ENVISION Trial of UGN-102

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions